Please provide your email address to receive an email when new articles are posted on . More than 14 million people aged younger than 65 years have compromised immune systems. Delays in diagnosis ...

Please provide your email address to receive an email when new articles are posted on . Genetic testing is driving the increased number of diagnoses. Physicians who lack access to testing are ...

CASTELVECCHIO PASCOLI, Italy, Nov. 6, 2025 /PRNewswire/ -- Kedrion Biopharma, a biopharmaceutical company specializing in plasma-derived therapies, announces its participation at the International ...

Primary immunodeficiencies (PIDs) are a heterogeneous group of conditions that result from mutations in over 300 different genes and are characterized by varying degrees of abnormal immune cell ...

Scientists have described an exquisitely balanced interplay of four molecules that trigger and govern antibody production in immune cells. As well as being an important basic science discovery, it ...

BMT is curative in almost 75% of children affected by severe primary immunodeficiencies (PIDs). Recently, the chance of cure has increased thanks to the availability of matched unrelated donors (MUDs) ...

BARCELONA, Spain, June 17, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), one of the world’s leading producers of plasma-derived medicines, today announced that Biotest, a Grifols ...

In a recent study published in Nature Communications, researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. Study: CRISPR-Cas9 ...

Vanessa Bryant is a Sir Clive McPherson Family Centenary Fellow and Royal Melbourne Hospital DW Keir Fellow and also receives funding from NHMRC, Holmes Grant Charitable trust, WEHI Innovation Fund, ...

Researchers from the University of Freiburg, Germany have developed a functional flow cytometry-based method for the diagnosis of innate primary immunodeficiencies (PIDs). The technique was applied to ...

Intravenous immunoglobulin (IVIg) is a treatment that can boost antibody levels in people with immunodeficiencies, autoimmune diseases, or inflammatory conditions. It contains antibodies, which are ...